Documents

A list of downloadable documents created during development.

Background information

Renal cell carcinoma (advanced) - axitinib: review decision - December 2014 information
Renal cell carcinoma (advanced) - axitinib: appendix A - GE Decision paper November 2014 ^{PDF 124.46 KB} 16 March 2015

Renal cell carcinoma (advanced) - axitinib: equality impact assessment

Renal cell carcinoma (advanced) - axitinib: equality impact assessment ^{PDF 184.27 KB} 25 February 2015

Renal cell carcinoma (advanced) - axitinib [ID518]: 2nd final appraisal determination

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the updated scope and provisional matrix (post-appeal)

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the updated scope and provisional matrix (post-appeal) ^{PDF 132.03 KB} 04 October 2013

Renal cell carcinoma (advanced) - axitinib: appeal

Renal cell carcinoma (advanced) - axitinib: final appraisal determination

Renal cell carcinoma (advanced) - axitinib: final appraisal determination information
Renal cell carcinoma (advanced) - axitinib: final appraisal determination document ^{PDF 243.04 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: response to consultee, commentator and public comments on the Appraisal Consultation Document ^{PDF 253.45 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: consultee and commentator comments on the ACD
Renal cell carcinoma (advanced) - axitinib: Pfizer ^{PDF 706.75 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: Commissioning Support Appraisal Service ^{PDF 153.92 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer ^{PDF 49.13 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK ^{PDF 16.29 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: Hawkins ^{PDF 58.39 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: comments on the ACD received from the public through the NICE website ^{PDF 37.7 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: manufacturer revised PAS submission template ^{PDF 351.82 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: manufacturer additional evidence, updated basecase and PAS ^{PDF 127.02 KB} 28 March 2013
Renal cell carcinoma (advanced) - axitinib: ERG review of additional evidence, updated basecase and PAS ^{PDF 420.54 KB} 28 March 2013

Renal cell carcinoma (advanced) - axitinib: appraisal consultation

Renal cell carcinoma (advanced) - axitinib: appraisal consultation
Renal cell carcinoma (advanced) - axitinib: appraisal consultation document information
Renal cell carcinoma (advanced) - axitinib: Evaluation report
Renal cell carcinoma (advanced) - axitinib: Pre-meeting briefing ^{PDF 636.3 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Evidence Review Group report ^{PDF 2.2 MB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Erratum to the Evidence Review Group report ^{PDF 768.13 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Addendum to the Evidence Review Group report ^{PDF 260.38 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Evidence Review Group report - factual accuracy check ^{PDF 128.97 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Manufacturer submission
Renal cell carcinoma (advanced) - axitinib: Manufacturer submission - Pfizer ^{PDF 4.75 MB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Department of Health letter confirming PAS ^{PDF 43.92 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: PAS submission ^{PDF 428.62 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Clarification
Renal cell carcinoma (advanced) - axitinib: NICE clarification letter ^{PDF 149.82 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Manufacturer response to the NICE clarification letter ^{PDF 298.15 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Patient group, professional group and NHS organisation submission statements
Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer ^{PDF 115.74 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK ^{PDF 73.31 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Rarer Cancers Foundation ^{PDF 135.29 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: NHS Norfolk ^{PDF 69.83 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Expert written personal statements
Renal cell carcinoma (advanced) - axitinib: Brown and Hawkins (joint statement) ^{PDF 108.34 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Hanlon ^{PDF 177.5 KB} 07 December 2012
Renal cell carcinoma (advanced) - axitinib: Lowe ^{PDF 76.34 KB} 07 December 2012

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the draft scope and provisional matrix (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the draft scope and provisional matrix (pre-appeal) ^{PDF 118.78 KB} 25 June 2012

Renal cell carcinoma (advanced) - axitinib: final matrix (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: final matrix (pre-appeal) ^{PDF 51.15 KB} 25 June 2012

Renal cell carcinoma (advanced) - axitinib: final scope (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: final scope (pre-appeal) ^{PDF 56.24 KB} 25 June 2012

Renal cell carcinoma (advanced) - axitinib: Appendix B - draft scope for consultation (pre-referral) - September 2011

Renal cell carcinoma (advanced) - axitinib: Appendix B - draft scope for consultation (pre-referral) - September 2011 ^{PDF 103.84 KB} 21 March 2012

Renal cell carcinoma (advanced) - axitinib: Appendic C - provisional matrix (pre-referral) - September 2011

Renal cell carcinoma (advanced) - axitinib: Appendic C - provisional matrix (pre-referral) - September 2011 ^{PDF 100.15 KB} 21 March 2012

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

Background information

Renal cell carcinoma (advanced) - axitinib: equality impact assessment

Renal cell carcinoma (advanced) - axitinib [ID518]: 2nd final appraisal determination

Renal cell carcinoma (advanced) - axitinib: appraisal consultation 2

Renal cell carcinoma (advanced) - axitinib: final scope (post-appeal)

Renal cell carcinoma (advanced) - axitinib: final matrix (post-appeal)

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the updated scope and provisional matrix (post-appeal)

Renal cell carcinoma (advanced) - axitinib: appeal

Renal cell carcinoma (advanced) - axitinib: final appraisal determination

Renal cell carcinoma (advanced) - axitinib: appraisal consultation

Renal cell carcinoma (advanced) - axitinib: response to consultee and commentator comments on the draft scope and provisional matrix (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: final matrix (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: final scope (pre-appeal)

Renal cell carcinoma (advanced) - axitinib: Appendix B - draft scope for consultation (pre-referral) - September 2011

Renal cell carcinoma (advanced) - axitinib: Appendic C - provisional matrix (pre-referral) - September 2011